Chemometrics tools used in analytical chemistry: An overview N Kumar, A Bansal, GS Sarma, RK Rawal Talanta 123, 186-199, 2014 | 406 | 2014 |
Role of sulphur-heterocycles in medicinal chemistry: An update S Pathania, RK Narang, RK Rawal European journal of medicinal chemistry 180, 486-508, 2019 | 301 | 2019 |
2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors RK Rawal, YS Prabhakar, SB Katti, E De Clercq Bioorganic & medicinal chemistry 13 (24), 6771-6776, 2005 | 286 | 2005 |
Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review R Kaur, S Chaudhary, K Kumar, MK Gupta, RK Rawal European Journal of Medicinal Chemistry 132, 108-134, 2017 | 261 | 2017 |
Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1, 3-thiazolidin-4-ones as anti-HIV agents RK Rawal, R Tripathi, SB Katti, C Pannecouque, E De Clercq Bioorganic & medicinal chemistry 15 (4), 1725-1731, 2007 | 257 | 2007 |
Synthetic and Medicinal Perspective of Thiazolidinones: A Review SK Manjal, R Kaur, R Bhatia, K Kumar, V Singh, R Shankar, R Kaur, ... Bioorganic Chemistry 75, 406-423, 2017 | 185 | 2017 |
Chemometrics: A new scenario in herbal drug standardization A Bansal, V Chhabra, RK Rawal, S Sharma Journal of Pharmaceutical Analysis 4 (4), 223-233, 2014 | 185 | 2014 |
Synthesis and evaluation of 2-(2, 6-dihalophenyl)-3-pyrimidinyl-1, 3-thiazolidin-4-one analogues as anti-HIV-1 agents RK Rawal, R Tripathi, SB Katti, C Pannecouque, E De Clercq Bioorganic & medicinal chemistry 15 (9), 3134-3142, 2007 | 177 | 2007 |
Design and synthesis of 2-(2, 6-dibromophenyl)-3-heteroaryl-1, 3-thiazolidin-4-ones as anti-HIV agents RK Rawal, R Tripathi, SB Katti, C Pannecouque, E De Clercq European journal of medicinal chemistry 43 (12), 2800-2806, 2008 | 162 | 2008 |
Recent advances in the chemistry and biology of benzothiazoles RK Gill, RK Rawal, J Bariwal Archiv der Pharmazie 348 (3), 155-178, 2015 | 149 | 2015 |
Diversity-oriented synthesis of fused-imidazole derivatives via Groebke–Blackburn–Bienayme reaction: a review N Devi, RK Rawal, V Singh Tetrahedron 71 (2), 183-232, 2015 | 143 | 2015 |
Recent synthetic and medicinal perspectives of tryptanthrin R Kaur, SK Manjal, RK Rawal, K Kumar Bioorganic & medicinal chemistry 25 (17), 4533-4552, 2017 | 142 | 2017 |
Medicinal attributes of imidazo [1, 2-a] pyridine derivatives: an update N Devi, D Singh, R K Rawal, J Bariwal, V Singh Current topics in medicinal chemistry 16 (26), 2963-2994, 2016 | 109 | 2016 |
Drug metabolizing enzymes and their inhibitors' role in cancer resistance S Pathania, R Bhatia, A Baldi, R Singh, RK Rawal Biomedicine & Pharmacotherapy 105, 53-65, 2018 | 107 | 2018 |
CP‐MLR/PLS Directed Structure‐Activity Modeling of the HIV‐1 RT Inhibitory Activity of 2, 3‐Diaryl‐1, 3‐thiazolidin‐4‐ones YS Prabhakar, VR Solomon, RK Rawal, MK Gupta, SB Katti QSAR & Combinatorial Science 23 (4), 234-244, 2004 | 106 | 2004 |
Polysaccharides based nanomaterials for targeted anti-cancer drug delivery D Dheer, D Arora, S Jaglan, RK Rawal, R Shankar Journal of drug targeting 25 (1), 1-16, 2017 | 103 | 2017 |
The critical role of bisphosphonates to target bone cancer metastasis: an overview T Singh, V Kaur, M Kumar, P Kaur, RSR Murthy, RK Rawal Journal of Drug Targeting 23 (1), 1-15, 2015 | 83 | 2015 |
An expeditious synthesis of thiazolidinones and tetathiazanones RK Rawal, T Srivastava, W Haq, SB Katti Journal of Chemical Research 2004 (5), 368-369, 2004 | 76 | 2004 |
Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1, 3-thiazolidin-4-one derivatives RK Rawal, SB Katti, N Kaushik-Basu, P Arora, Z Pan Bioorganic & medicinal chemistry letters 18 (23), 6110-6114, 2008 | 73 | 2008 |
Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines Z Wang, J Martinez, W Zhou, C La Rosa, T Srivastava, A Dasgupta, ... Vaccine 28 (6), 1547-1557, 2010 | 69 | 2010 |